| Title |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2020
|
| DOI | 10.1002/14651858.cd012852.pub2 |
| Pubmed ID | |
| Authors |
Eva N Hamulyák, Luuk Jj Scheres, Mauritia C Marijnen, Mariëtte Goddijn, Saskia Middeldorp |
X Demographics
The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 17 | 30% |
| United Kingdom | 5 | 9% |
| Spain | 4 | 7% |
| Netherlands | 3 | 5% |
| Malawi | 1 | 2% |
| Canada | 1 | 2% |
| Ecuador | 1 | 2% |
| Czechia | 1 | 2% |
| Brazil | 1 | 2% |
| Other | 4 | 7% |
| Unknown | 19 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 72% |
| Scientists | 9 | 16% |
| Practitioners (doctors, other healthcare professionals) | 7 | 12% |
Mendeley readers
The data shown below were compiled from readership statistics for 297 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 297 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 39 | 13% |
| Student > Master | 27 | 9% |
| Student > Postgraduate | 23 | 8% |
| Researcher | 20 | 7% |
| Student > Ph. D. Student | 20 | 7% |
| Other | 42 | 14% |
| Unknown | 126 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 90 | 30% |
| Nursing and Health Professions | 20 | 7% |
| Biochemistry, Genetics and Molecular Biology | 8 | 3% |
| Agricultural and Biological Sciences | 8 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 2% |
| Other | 24 | 8% |
| Unknown | 142 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 51. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2023.
All research outputs
#850,611
of 26,033,965 outputs
Outputs from Cochrane database of systematic reviews
#1,538
of 13,180 outputs
Outputs of similar age
#24,858
of 413,794 outputs
Outputs of similar age from Cochrane database of systematic reviews
#32
of 191 outputs
Altmetric has tracked 26,033,965 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,180 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,794 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 191 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.